4.6 Article

Dyclonine relieves the Parkinson's disease progression in rotenone-induced Drosophila model

Related references

Note: Only part of the references are listed.
Article Neurosciences

Impact of age on the rotenone-induced sporadic Parkinson's disease model using Drosophila melanogaster

Wanrui Li et al.

Summary: The study investigated the impact of age on the rotenone-induced PD model in Drosophila. The results showed that older flies displayed typical PD features, including the loss of DA neurons, decreased TH expression levels, and decreased locomotive ability. In contrast, 1-day-old flies showed unstable motor deficits and minimal TH expression changes after rotenone exposure. Additionally, the death rate of flies rapidly increased with increasing starting age after 7 days of rotenone exposure.

NEUROSCIENCE LETTERS (2023)

Review Neurosciences

Drosophila: A Model to Study the Pathogenesis of Parkinson's Disease

Rahul et al.

Summary: The human central nervous system is a complex part of the body that regulates multiple cellular and molecular events. Parkinson's disease is the second most common neurodegenerative disease after Alzheimer's disease. Drosophila melanogaster is an appropriate model organism for studying neurodegenerative diseases due to its similarities with humans.

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2022)

Review Biochemistry & Molecular Biology

An Overview of Oxidative Stress, Neuroinflammation, and Neurodegenerative Diseases

Daniel Mihai Teleanu et al.

Summary: This review summarizes the correlation between oxidative stress and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis. It also discusses the impact of oxidative stress on the inflammatory response. Antioxidants are considered potential therapeutic options for these disorders.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Biochemistry & Molecular Biology

Neuroinflammation in Friedreich's Ataxia

Savina Apolloni et al.

Summary: Friedreich's ataxia (FRDA) is a rare genetic disorder caused by mutations in the frataxin gene, leading to progressive nervous system damage. In addition to neurons, alterations in glial cells and neuroinflammatory-related mechanisms may contribute to the pathogenesis of FRDA.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Biochemistry & Molecular Biology

α-Syn overexpression, NRF2 suppression, and enhanced ferroptosis create a vicious cycle of neuronal loss in Parkinson's disease

A. Anandhan et al.

Summary: Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the accumulation of alpha-synuclein and its negative effects on neuronal function and viability. This study demonstrates that loss of NRF2, a critical anti-ferroptotic mediator, increases markers of ferroptosis in PD-relevant brain regions. The increased ferroptosis is associated with age and genotype-dependent increase in alpha-syn pathology and behavioral deficits. The findings suggest targeting the vicious cycle of alpha-syn overexpression and NRF2 suppression as a potential means of preventing PD onset and progression.

FREE RADICAL BIOLOGY AND MEDICINE (2022)

Review Cell Biology

The role of Nrf2 in neural stem/progenitors cells: From maintaining stemness and self-renewal to promoting differentiation capability and facilitating therapeutic application in neurodegenerative disease

Houman Kahroba et al.

Summary: Neurodegenerative diseases are characterized by the progressive loss of neurons in the nervous system, with oxidative stress, inflammation, and synaptic dysfunction being key hallmarks. Neural stem cells play a crucial role in adult neurogenesis in certain regions of the brain, and the transcription factor Nrf2 can influence NSC function and fate determination by maintaining redox homeostasis and reducing reactive oxygen species levels. Promising strategies for treating NDs include protecting neural cells from oxidative damage and supporting neurogenesis.

AGEING RESEARCH REVIEWS (2021)

Review Medicine, General & Internal

Parkinson's disease

Bastiaan R. Bloem et al.

Summary: Parkinson's disease is a neurodegenerative condition with diverse causes and clinical presentations. Diagnosis is clinically based, and treatment goals vary from person to person, emphasizing the need for personalized management. Currently, there is no therapy to slow down or arrest the progression of Parkinson's disease.

LANCET (2021)

Review Biochemistry & Molecular Biology

Heme Oxygenase-1 Signaling and Redox Homeostasis in Physiopathological Conditions

Valeria Consoli et al.

Summary: Heme-oxygenase (HO-1) plays a crucial role in maintaining cellular oxidative damage and has implications in cancer research and antioxidant activity.

BIOMOLECULES (2021)

Review Medicine, General & Internal

Diagnosis and Treatment of Parkinson Disease A Review

Melissa J. Armstrong et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Multidisciplinary Sciences

Neuron-based high-content assay and screen for CNS active mitotherapeutics

Boglarka H. Varkuti et al.

SCIENCE ADVANCES (2020)

Review Clinical Neurology

Parkinson disease and the immune system - associations, mechanisms and therapeutics

Eng-King Tan et al.

NATURE REVIEWS NEUROLOGY (2020)

Article Pharmacology & Pharmacy

Protective effect of (-)-α-bisabolol on rotenone-induced toxicity in Drosophila melanogaster

Gerlania de Oliveira Leite et al.

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2018)

Article Genetics & Heredity

Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson s disease a multicenter study

Malin von Otter et al.

BMC MEDICAL GENETICS (2014)

Article Biochemistry & Molecular Biology

Dyclonine rescues frataxin deficiency in animal models and buccal cells of patients with Friedreich's ataxia

Sunil Sahdeo et al.

HUMAN MOLECULAR GENETICS (2014)

Article Neurosciences

Valeriana officinalis attenuates the rotenone-induced toxicity in Drosophila melanogaster

Jessie Haigert Sudati et al.

NEUROTOXICOLOGY (2013)

Review Medicine, General & Internal

Parkinson's disease

Andrew J. Lees et al.

LANCET (2009)

Article Multidisciplinary Sciences

Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte

Pei-Chun Chen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Neurosciences

Nrf2--mediated protection against 6-hydroxydopamine

Rebekah J. Jakel et al.

BRAIN RESEARCH (2007)

Article Biochemistry & Molecular Biology

A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster

LT Reiter et al.

GENOME RESEARCH (2001)